Nadia Nabulsi, MPH, PhD

Healthcare Resource Utilization and Costs of Using Cariprazine as the First Versus Subsequent Adjunctive Therapy for Major Depressive Disorder

Adjunctive therapy with atypical antipsychotics is a treatment option for patients diagnosed with major depressive disorder and inadequate response to antidepressant monotherapy. This cla...

Nadia Nabulsi , MPH, PhD;

10/26/2023

Impact of Adjunctive Cariprazine on Quality of Life in Major Depressive Disorder: A Post Hoc Analysis

Patients with major depressive disorder often have reduced quality of life. A previous phase 3 trial showed cariprazine adjunctive to antidepressant therapy reduces depressive symptoms in...

Nadia Nabulsi , MPH, PhD;

10/26/2023